{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T20:20:33Z","timestamp":1787775633317,"version":"build-2784847793"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10]]},"abstract":"\n Background:<\/jats:title>\n Few studies have explored the anti-inflammatory effects of drugs in cardiac surgery. Dexmedetomidine (Dex), a centrally acting alpha-agonist, is believed to possess anti-inflammatory properties. We conducted a randomized, double-blind, controlled trial to assess the anti-inflammatory effects of Dex in patients undergoing open-heart surgery with cardiopulmonary bypass.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n Adult eligible patients undergoing cardiac surgery with cardiopulmonary bypass were randomly assigned to receive either standard anesthetics or De \u00d7 0.5 \u03bcg\/kg\/h in addition to anesthetics in a single-center, randomized, double-blinded study. The primary outcome was the change in inflammatory mediators (\u2206) in plasma 24 hours postsurgery compared with baseline, measured by ELISA. Secondary outcomes are defined as changes in hemodynamic and biological markers, recovery time, and Dex\u2019s safety.<\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n In total, 80 patients were included in the control and Dex groups. The Dex group increased IL-13 levels as anti-inflammatory cytokines, while it was decreased in the control group. Dex reduced the levels of interleukin (IL)-6 (\n P<\/jats:italic>\n = 0.777) and IL-18 (\n P<\/jats:italic>\n = 0.895) at the 24 hours postsurgery, with no statically significant difference against the control group. Both groups did not increase the levels of IL-1\u03b2 and TNF-\u03b1 regards to baseline (\n P<\/jats:italic>\n = 0.812 and\n P<\/jats:italic>\n = 0.420, respectively); however, this increase was lower in the Dex group for TNF-\u03b1 and slightly higher for IL-1\u03b2. Dex provided better hemodynamic and repository stability. In addition, the incidence of common events including hypotension, bradycardia, and tachycardia was higher in the control group than in Dex.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n We found that administering Dex at the onset of anesthesia and during cardiopulmonary bypass reduces inflammatory factors, promotes hemodynamic stability, and enhances patient safety. It may offer significant benefits for those undergoing open heart surgery.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/aca.aca_5_25","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T16:12:18Z","timestamp":1760371938000},"page":"401-409","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Dexmedetomidine Improves Inflammatory Stress and Hemodynamic in Patients Undergoing Open Heart Surgery via Interleukin-13: A Randomized, Double-Blind, Controlled, Clinical Trial"],"prefix":"10.4103","volume":"28","author":[{"given":"Bassim Mohammed Jabbar","family":"Hatemi","sequence":"first","affiliation":[{"name":"Ischemic Disorders Research Center, International Campus, Golestan University of Medical Sciences, Gorgan, Iran"},{"name":"Anesthesia Techniques Department, College of Health and Medical Techniques, Al-Mustaqbal University, Babylon, Hillah, Iraq"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesheh","family":"Enayati","sequence":"additional","affiliation":[{"name":"Ischemic Disorders Research Center, Jorjani Clinical Sciences Research Institute, Golestan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somayeh","family":"Ghorbani","sequence":"additional","affiliation":[{"name":"Cancer Research Center, Golestan University of Medical Sciences, Gorgan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Tahmasebi","sequence":"additional","affiliation":[{"name":"Ischemic Disorders Research Center, Jorjani Clinical Sciences Research Institute, Golestan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi Abo","family":"Aljadayel","sequence":"additional","affiliation":[{"name":"Ischemic Disorders Research Center, Jorjani Clinical Sciences Research Institute, Golestan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Jabbari","sequence":"additional","affiliation":[{"name":"Ischemic Disorders Research Center, Jorjani Clinical Sciences Research Institute, Golestan"},{"name":"Department of Anesthesiology and Critical Care Medicine, Golestan University of Medical Sciences, Gorgan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Movafegh","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, School of Medicine faculty, Tehran University of Medical Sciences, Tehran, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"R1-20260420","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.atssr.2023.11.019","article-title":"Global cardiac surgical volume and gaps: Trends, targets, and way forward","volume":"2","author":"Vervoort","year":"2024","journal-title":"Ann Thorac Surg Short Rep"},{"key":"R2-20260420","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3892\/etm.2020.9380","article-title":"Effect of dexmedetomidine on hemodynamic changes and inflammatory responses in patients undergoing offpump coronaryartery bypass grafting","volume":"20","author":"Zhai","year":"2020","journal-title":"Exp Ther Med"},{"key":"R3-20260420","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12872-024-03860-9","article-title":"Heart surgery over two decades: What we have learned about results and changing risks","volume":"24","author":"Tajdini","year":"2024","journal-title":"BMC Cardiovasc Disord"},{"key":"R4-20260420","first-page":"192","article-title":"Stressors in open-heart surgery patients: A qualitative study","volume":"15","author":"Sedaghat","year":"2019","journal-title":"ARYA Atheroscler"},{"key":"R5-20260420","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1177\/1074248411410318","article-title":"Myocardial protection in heart surgery","volume":"16","author":"Mentzer","year":"2011","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"R6-20260420","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00540-021-02982-0","article-title":"Myocardial protective and anti-inflammatory effects of dexmedetomidine in patients undergoing cardiovascular surgery with cardiopulmonary bypass: A systematic review and meta-analysis","volume":"36","author":"Chen","year":"2022","journal-title":"J Anesth"},{"key":"R7-20260420","doi-asserted-by":"crossref","first-page":"117177","DOI":"10.1016\/j.biopha.2024.117177","article-title":"The interplay between cytokines, inflammation, and antioxidants: Mechanistic insights and therapeutic potentials of various antioxidants and anti-cytokine compounds","volume":"178","author":"Bhol","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"R8-20260420","doi-asserted-by":"crossref","first-page":"e172702","DOI":"10.1172\/jci.insight.172702","article-title":"IL-13 promotes functional recovery after myocardial infarction via direct signaling to macrophages","volume":"9","author":"Alvarez-Argote","year":"2024","journal-title":"JCI Insight"},{"key":"R9-20260420","doi-asserted-by":"crossref","first-page":"e4646","DOI":"10.1590\/1414-431X20154646","article-title":"Dexmedetomidine decreases the inflammatory response to myocardial surgery under mini-cardiopulmonary bypass","volume":"49","author":"Bulow","year":"2016","journal-title":"Braz J Med Biol Res"},{"key":"R10-20260420","first-page":"3307","article-title":"Protective effects of dexmedetomidine on hypoxia\/reoxygenation injury in cardiomyocytes by regulating the CHOP signaling pathway","volume":"22","author":"Shi","year":"2020","journal-title":"Mol Med Rep"},{"key":"R11-20260420","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/FJC.0000000000000698","article-title":"Effects of pre\u2013cardiopulmonary bypass administration of dexmedetomidine on cardiac injuries and the inflammatory response in valve replacement surgery with a sevoflurane postconditioning protocol: A pilot study","volume":"74","author":"Zhou","year":"2019","journal-title":"J Cardiovasc Pharmacol"},{"key":"R12-20260420","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/anae.12636","article-title":"The effects of dexmedetomidine on inflammatory mediators after cardiopulmonary bypass","volume":"69","author":"Ueki","year":"2014","journal-title":"Anaesthesia"},{"key":"R13-20260420","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.bja.2019.07.027","article-title":"Effects of dexmedetomidine on perioperative stress, inflammation, and immune function: Systematic review and meta-analysis","volume":"123","author":"Wang","year":"2019","journal-title":"Br J Anaesth"},{"key":"R14-20260420","first-page":"21166","article-title":"Effect of dexmedetomidine on myocardial ischemia-reperfusion injury","volume":"8","author":"Chen","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"R15-20260420","first-page":"6482","article-title":"The effects of dexmedetomidine on inflammatory responses in patients undergoing valve replacement surgery with cardiopulmonary bypass","volume":"10","author":"Huang","year":"2017","journal-title":"Int J Clin Exp Med"},{"key":"R16-20260420","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/11101849.2020.1849957","article-title":"The effect of dexmedetomidine on the inflammatory response in children undergoing repair of congenital heart disease: A randomized controlled clinical trial","volume":"36","author":"Abdelrahman","year":"2020","journal-title":"Egypt J Anaesth"},{"key":"R17-20260420","doi-asserted-by":"crossref","first-page":"746494","DOI":"10.3389\/fphys.2021.746494","article-title":"Inflammation in human heart failure: Major mediators and therapeutic targets","volume":"12","author":"Reina-Couto","year":"2021","journal-title":"Front Physiol"},{"key":"R18-20260420","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s13063-023-07384-z","article-title":"Effects of dexmedetomidine at different dosages on perioperative haemodynamics and postoperative recovery quality in elderly patients undergoing hip replacement surgery under general anaesthesia: A randomized controlled trial","volume":"24","author":"Liu","year":"2023","journal-title":"Trials"},{"key":"R19-20260420","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1161\/CIRCULATIONAHA.121.056940","article-title":"Cytokine hemoadsorption during cardiac surgery versus standard surgical care for infective endocarditis (REMOVE): Results from a multicenter randomized controlled trial","volume":"145","author":"Diab","year":"2022","journal-title":"Circulation"},{"key":"R20-20260420","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3390\/jcm11030590","article-title":"Characteristics of interleukin-6 signaling in elective cardiac surgery\u2014A prospective cohort study","volume":"11","author":"Puchinger","year":"2022","journal-title":"J Clin Med"},{"key":"R21-20260420","doi-asserted-by":"crossref","first-page":"5351","DOI":"10.1111\/jcmm.16566","article-title":"Emerging role of interleukin-13 in cardiovascular diseases: A ray of hope","volume":"25","author":"Qian","year":"2021","journal-title":"J Cell Mol Med"},{"key":"R22-20260420","doi-asserted-by":"crossref","first-page":"99495","DOI":"10.18632\/oncotarget.20111","article-title":"Interleukin-13 reduces cardiac injury and prevents heart dysfunction in viral myocarditis via enhanced M2 macrophage polarization","volume":"8","author":"Yang","year":"2017","journal-title":"Oncotarget"},{"key":"R23-20260420","doi-asserted-by":"crossref","first-page":"919973","DOI":"10.3389\/fimmu.2022.919973","article-title":"Interleukin-18 cytokine in immunity, inflammation, and autoimmunity: Biological role in induction, regulation, and treatment","volume":"13","author":"Ihim","year":"2022","journal-title":"Front Immunol"},{"key":"R24-20260420","doi-asserted-by":"crossref","first-page":"110141","DOI":"10.1016\/j.cellsig.2021.110141","article-title":"Interleukin-18 accelerates cardiac inflammation and dysfunction during ischemia\/reperfusion injury by transcriptional activation of CXCL16","volume":"87","author":"Zhao","year":"2021","journal-title":"Cell Signal"},{"key":"R25-20260420","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/eurheartj\/ehx261","article-title":"IL-18 cleavage triggers cardiac inflammation and fibrosis upon \u03b2-adrenergic insult","volume":"39","author":"Xiao","year":"2018","journal-title":"Eur Heart J"},{"key":"R26-20260420","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.mehy.2017.05.009","article-title":"Endothelial dysfunction mediated by interleukin-18 in patients with ischemic heart disease undergoing coronary artery bypass grafting surgery","volume":"104","author":"Jadranko","year":"2017","journal-title":"Med Hypotheses"},{"key":"R27-20260420","doi-asserted-by":"crossref","first-page":"104371","DOI":"10.1016\/j.yexmp.2020.104371","article-title":"Dexmedetomidine reduces the inflammation and apoptosis of doxorubicin-induced myocardial cells","volume":"113","author":"He","year":"2020","journal-title":"Exp Mol Pathol"},{"key":"R28-20260420","first-page":"1","article-title":"Dexmedetomidine attenuates myocardial ischemia-reperfusion injury in vitro by inhibiting NLRP3 Inflammasome activation","volume":"21","author":"Huang","year":"2021","journal-title":"BMC Anesthesiol"},{"key":"R29-20260420","first-page":"e157117","article-title":"Double-blind, randomized, controlled pilot trial to specify collateral effect and safety of perioperative dexmedetomidine in patients undergoing open heart surgery","volume":"15","author":"Hatemi","year":"2025","journal-title":"Anesth Pain Med"},{"key":"R30-20260420","doi-asserted-by":"crossref","first-page":"2327143","DOI":"10.1080\/2162402X.2024.2327143","article-title":"Trial watch: Dexmedetomidine in cancer therapy","volume":"13","author":"Carnet Le Provost","year":"2024","journal-title":"Oncoimmunology"},{"key":"R31-20260420","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11916-020-00853-z","article-title":"Dexmedetomidine in enhanced recovery after surgery (ERAS) protocols for postoperative pain","volume":"24","author":"Kaye","year":"2020","journal-title":"Curr Pain Headache Rep"}],"container-title":["Annals of Cardiac Anaesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/aca.aca_5_25","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:36:58Z","timestamp":1787773018000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aca.aca_5_25"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/aca.aca_5_25","relation":{},"ISSN":["0971-9784","0974-5181"],"issn-type":[{"value":"0971-9784","type":"print"},{"value":"0974-5181","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"2025-01-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-03-03","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}